GeneDx
Buying intent
151 tracked signals | Top 15 topics are below | Sales and Marketing are carrying most of it.
Attention by team
LinkedIn activity, by teamWhere GeneDx's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.
Topics being researched
30-day windowEvery tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.
10d ago
9d ago
17d ago
10d ago
10d ago
10d ago
12d ago
13d ago
19d ago
10d ago
17d ago
18d ago
18d ago
9d ago
18d ago
Need intent for a specific topic or industry?
We track the full taxonomy across every account in the graph — including themes not shown on this page.
Who's active at GeneDx
verified title on fileTitles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.
See everyone, not just the first 10
19 people across every department at GeneDx, plus a LinkedIn profile link for each.
Primary products / business lines
LinkedIn company profileWe see a world where every genetic condition is understood, and every patient receives the care they need to live their healthiest life through genomics. GeneDx combines unmatched clinical expertise, advanced technology, and the power of GeneDx Infinity™, the world’s largest rare disease genomic dataset. This unparalleled foundation powers GeneDx’s ExomeDx™ and GenomeDx™ tests – ranked #1 by ex
New capability sought
Employee posts (LinkedIn)Patient Advocacy; Precision Medicine; Business Model; Clinical Trials; Digital Health; Drug Development; Healthcare Interoperability; MBA Programs
Top accounts researching GeneDx
names withheld on the public pageThese are companies whose own people brought up GeneDx unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.
151,426 companies · 839,012 people are researching Artificial Intelligence
GeneDx's own team shows 16 signals on this topic. No one outside GeneDx has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.
- Hiring75,708 cos · 411,263 people
- Precision Medicine1,307 cos · 4,297 people
Buyer profile
company size · seniorityCompany size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.
Buying committee functions
Employee job titles (LinkedIn)Leadership — 2 people; Sales — 2 people; Engineering — 1 person; Marketing — 1 person; HR / Talent — 1 person; Product — 1 person; IT — 1 person
What's been said
public posts mentioning GeneDxUp to 9 public excerpts naming GeneDx from the past 365 days, across LinkedIn, Reddit, X, YouTube and other public sources.
👋👋👋 #ISPORAnnual ! GeneDx is excited to be here. Come and see us at booth #837! We will show you GeneDx Infinity, one of the world’s largest genomic datasets. With Andrew Pollock, PhD , Sindhu Raghunandan, PhD , Colleen Caleshu MSc, LCGC, PhD Candidate , Jessica Merritt , Susan Williams , Amanda Ventrella , Bridget Boelter #ISPOR #ISPOR2026
May 2026🚀 Excited for #ISPOR2026 Day 2 - stop by booth #837 to learn about GeneDx Infinity, one of the world's largest genomic datasets!
May 2026#NEWS UPDATE: Today, we’re excited to announce new GeneDx Infinity™ data and tools to fuel biopharma drug discovery, accelerate clinical trials, and advance health economics outcomes research (HEOR). GeneDx Infinity is growing rapidly – adding 30% more genomic tests in 2025 than the prior 24 years combined–and each patient tested contributes more data to Infinity, which now includes: • More than 2.5 million genetic tests, including over 1 million exomes and genomes • More than 1.4 billion clinical datapoints, including clinical notes • More than 8 million mapped phenotypic datapoints • Integrated longitudinal claims data from Komodo Health ’s Research Dataset, spanning 7 years on average and 92% overlap • More than 1.5 million contactable patients, representative of the US News link ⬇️ Stop by our booth #837 for a demo at ISPOR—The Professional Society for Health Economics and Outcomes Research . I'd love to meet you. #ISPORAnnual #ISPOR2026 #RWD #genomics #HEOR
May 2026Looking forward to the ISPOR—The Professional Society for Health Economics and Outcomes Research event in Philadelphia next week! Visit the GeneDx team at booth #837 - I'd love to meet you and show you GeneDx Infinity, one of the world's largest genomic datasets, in action. If you're a biopharma or biotech company interested in advancing drug discovery, accelerating clinical trials, or advancing HEOR research, we'd love to meet and discuss how we can help you quickly and efficiently reach your goals. The power of 2.5M genetic tests + 8M mapped phenotypic datapoints + claims deliver an unprecedented opportunity for human genetics to enable actionable discoveries and precision medicine at speed and scale. #ISPORAnnual #ISPOR #GeneDx #precisionmedicine
May 2026Important #raredisease technical paper from Joseph Devaney , Britt Johnson, PhD, FACMG , Mike Bamshad, and colleagues at GeneDx and Seattle Children's assessing the use of PacBio HiFi #longread genome sequencing using real-world patient clinical samples. Very high yield (99.6%) across a variety of diagnostically important alterations, with the only 2 'misses' being in the context of mosaicism. Favorable turn around time and low need for supplementary assays, but still work to be done with throughput and COGS.
May 2026Strategic priorities
Earnings call; SEC filingsCompetitive Advantage; Data asset; Sales Cycle; Customer Segments; Take Note (+1 more)
What changed recently
Earnings call; SEC filingsCompetitive Advantage; Data asset; Sales Cycle; Customer Segments; Take Note; Revenue Cycle Management Software